Landmark Studies: The STAR*D Trial

<p>We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial.</p><p><br></p><p><strong>References:</strong></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/12778843/">https://pubmed.ncbi.nlm.nih.gov/12778843/</a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/19880458/">https://pubmed.ncbi.nlm.nih.gov/19880458/</a></p><p><a href="https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482026?utm_source=openevidence&utm_medium=referral">https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482026</a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/15061154/">https://pubmed.ncbi.nlm.nih.gov/15061154/</a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/20370962/">https://pubmed.ncbi.nlm.nih.gov/20370962/</a></p><p><a href="https://pubmed.ncbi.nlm.nih.gov/37491091/">https://pubmed.ncbi.nlm.nih.gov/37491091/</a></p><p><br></p><p><br></p>